Safety and Effectiveness of Inferior Vena Cava Filters Used to Protect Against Pulmonary Embolus: A Technology Assessment

Judith Walsh, MD, MPH



In This Article

Recommendations of Others

Blue Cross and Blue Shield Association (BCBSA)

The BCBSA Technology Evaluation Center (TEC) has not conducted an assessment of this technology.

Centers for Medicare and Medicaid Services (CMS)

A review of the CMS web site did not reveal any decisions specific to the use of IVC filters.

Society for Cardiovascular Angiography and Interventions (SCAI)

The SCAI, Society for Vascular Medicine and the CA ACC provided a joint statement regarding this technology. They did not participate at the meeting.

Society for Vascular Surgery (SVS)

The SVS has been invited to provide an opinion on this technology and to have a representative provide testimony at the meeting.

Society for Interventional Radiology (SIR)

SIR provided an opinion regarding the use of this technology. A representative was present at the meeting to provide testimony and participate in the discussion.

California Chapter of the American College of Cardiology (CAACC)

The CAACC provided a joint statement as noted above. A representative did not attend the meeting.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: